1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > North American Nuclear Medicine Market Outlook (2014-2022)

North American Nuclear Medicine Market Outlook (2014-2022)

  • October 2015
  • -
  • Stratistics MRC
  • -
  • 95 pages

The “North America Nuclear Medicine Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Nuclear Medicine market is segmented by application and by geography. Based on the application, the nuclear medicine market is categorized into diagnostics and therapeutics applications. The diagnostic application is further segmented into SPECT and PET market, where SPECT market comprises cardiology, neurology, thyroid and other diagnostic applications. The PET market comprises oncology and other PET applications. The therapeutics application is further segmented into thyroid, bone metastasis, endocrine tumors and other therapeutic applications. Based on the geography the market is categorized US, Canada, Mexico and Rest of North America.

The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.

Market Size Estimations
The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.

Company Profiling
This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.

Report Highlights:
- Market share assessments for all the mentioned market segments and sub-segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years for all the given segments
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping, mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Table Of Contents

North American Nuclear Medicine Market Outlook (2014-2022)
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 North American Nuclear Medicine Market By, Cockpit Applications
5.1 Introduction
5.2 Diagnostics
5.2.1 Single proton emission tomography (SPECT)
5.2.1.1 Cardiology
5.2.1.2 Neurology
5.2.1.3 Thyroid
5.2.1.4 Other SPECT applications
5.2.2 Positron emission tomography (PET)
5.2.2.1 Oncology
5.2.2.2 Other PET applications
5.3 Therapeutics
5.3.1 Thyroid
5.3.2 Bone metastasis
5.3.3 Endocrine tumors
5.3.4 Other therapeutic applications

6 North American Nuclear Medicine Market, By Geography
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.1.4 Rest of North America

7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions and Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
7.4 Expansions
7.5 Other Key Strategies

8 Company Profiling
8.1 GE Healthcare (U.K.)
8.2 Nordion, Inc. (Canada)
8.3 Bayer Healthcare (Germany)
8.4 Cardinal Health, Inc. (U.S.)
8.5 Siemens Healthcare (PETNET) (Germany)
8.6 IBA Group (Belgium)
8.7 Lantheus Medical Imaging, Inc. (U.S.)
8.8 Eczacibasi-Monrol Nuclear Products (Turkey)

List of Tables
1 North America Nuclear Medicin Market Outlook, By Countries (2012-2022) ($MN)
2 North America Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
3 US Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
4 Canada Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
5 Mexico Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
6 Rest of North America Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
7 North America Nuclear Medicine Market Outlook, By Diagnostics (2012-2022) ($MN)
8 North America Nuclear Medicine Market Outlook, By Single proton emission tomography (SPECT) (2012-2022) ($MN)
9 North America Nuclear Medicine Market Outlook, By Cardiology (2012-2022) ($MN)
10 North America Nuclear Medicine Market Outlook, By Neurology (2012-2022) ($MN)
11 North America Nuclear Medicine Market Outlook, By Thyroid (2012-2022) ($MN)
12 North America Nuclear Medicine Market Outlook, By Other SPECT applications (2012-2022) ($MN)
13 North America Nuclear Medicine Market Outlook, By Positron emission tomography (PET) (2012-2022) ($MN)
14 North America Nuclear Medicine Market Outlook, By Oncology (2012-2022) ($MN)
15 North America Nuclear Medicine Market Outlook, By Other PET applications (2012-2022) ($MN)
16 North America Nuclear Medicine Market Outlook, By Therapeutics (2012-2022) ($MN)
17 North America Nuclear Medicine Market Outlook, By Thyroid (2012-2022) ($MN)
18 North America Nuclear Medicine Market Outlook, By Bone metastasis (2012-2022) ($MN)
19 North America Nuclear Medicine Market Outlook, By Endocrine tumors (2012-2022) ($MN)
20 North America Nuclear Medicine Market Outlook, By Other therapeutic applications (2012-2022) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.